BioSpace News Archive

Kebotix, a Cambridge-based technology platform company for new chemicals and materials, announced SIT Capital as a major investor in its Series A funding.

PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, and Clinical Ink, a global clinical technology company, have jointly developed a systemic lupus erythematosus (SLE) assessment review process to simplify operationalizing clinical trials for this chronic autoimmune disease.

Hutchison China MediTech Limited (“HUTCHMED”) (Nasdaq/AIM: HCM) today announces that it has reached an agreement with GL Mountrose Investment Two Limited, a company controlled and managed by GL Capital Group (“GL Capital”), to sell its entire indirect interest in Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited (“HBYS”),

Ocean Genomics (Pittsburgh, PA), a world leader in AI-based gene expression analysis and RNA biomarker development, and Geninus (Seoul, South Korea), a leading full-service genomics laboratory, announce a strategic partnership for the purpose of co-developing RNA-based biomarkers and advancing research and clinical applications with hospital, academic and biotechnology clients

The agreement focuses on supporting the Company’s reach across the United States and Global marketplace business community along with extending policy advisory services in the U.S.

Moffitt Cancer C enter has adopted a new needle-free method of blood collection for patients in treatment who often need to undergo repeated needle sticks in a day, becoming the first cancer center in Florida to offer this pain-free technology as part of its world-class cancer care.

The Company is also pleased to provide a corporate update, including an update on its lead clinical development program.

Xlear has filed a Pre-Emergency Use Authorization (Pre-EUA) Request with the U.S. Food and Drug Administration (FDA) seeking approval to make claims that the nasal spray is approved for use in preventing SARS-CoV-2 (COVID-19) transmission and infection.

At today’s virtual combined Annual General Shareholders’ Meeting of Sartorius Stedim Biotech S.A., shareholders passed the resolution to pay a dividend of 0.68 euros per share for fiscal 2020

The World Health Organization commemorates World Tuberculosis Day to raise awareness about the health, social and economic consequences of this disease and to acknowledge the broader impact of COVID-19 for people with TB, including disruptions to essential TB services.